Neurology
-
Multicenter Study
Amyloid-β assessed by florbetapir F 18 PET and 18-month cognitive decline: a multicenter study.
Florbetapir F 18 PET can image amyloid-β (Aβ) aggregates in the brains of living subjects. We prospectively evaluated the prognostic utility of detecting Aβ pathology using florbetapir PET in subjects at risk for progressive cognitive decline. ⋯ Florbetapir PET may help identify individuals at increased risk for progressive cognitive decline.